Product Program year 2025 Source: CMS Open Payments

General - Therapies

Device General - Therapies_URO

Open in the dashboard

General payments

$21,636,837

2,344 payments

Research payments

$0

0 payments

Through program year 2025, $21,636,837 in general payments and $0 in research payments were reported against General - Therapies (General - Therapies_URO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $21,323,840 1,119
2022 General $312,996 1,225

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $21,636,837 2,344 payments
Top recipients General payments · program year 2025
  1. Matthew Allaway Urology · Cumberland, MD $20,592,559 97% · 2 payments
  2. Edward Schaeffer Urology · Chicago, IL $125,506 <1% · 1 payment
  3. Mariela Martinez-Rivera Urology · Ponce, PR $50,000 <1% · 1 payment
  4. Grace Chen Urology · Hackensack, NJ $30,000 <1% · 1 payment
  5. Adventhealth Orlando Teaching hospital · FL $25,188 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $21,114,596 99% · 253 practitioners
  2. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $84,974 <1% · 40 practitioners
  3. Obstetrics & Gynecology $27,901 <1% · 19 practitioners
  4. Radiation Oncology Radiology $25,480 <1% · 12 practitioners
  5. Cardiovascular Disease Internal Medicine $5,938 <1% · 4 practitioners

The top 5 of 25 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Maryland $20,605,786 97% · 10 recipients
  2. Illinois $142,699 <1% · 19 recipients
  3. New York $72,679 <1% · 22 recipients
  4. Florida $64,566 <1% · 45 recipients
  5. Puerto Rico $50,146 <1% · 3 recipients

The top 5 of 40 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,344 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record